{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:43:10Z","timestamp":1794915790675,"version":"4.9.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM125797"],"award-info":[{"award-number":["R01GM125797"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM115911"],"award-info":[{"award-number":["R01GM115911"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adeno-associated virus (AAV) vectors are important delivery platforms for therapeutic genome editing but are severely constrained by cargo limits. Simultaneous delivery of multiple vectors can limit dose and efficacy and increase safety risks. Here, we describe single-vector, ~4.8-kb AAV platforms that express Nme2Cas9 and either two sgRNAs for segmental deletions, or a single sgRNA with a homology-directed repair (HDR) template. We also use anti-CRISPR proteins to enable production of vectors that self-inactivate via Nme2Cas9 cleavage. We further introduce a nanopore-based sequencing platform that is designed to profile rAAV genomes and serves as a quality control measure for vector homogeneity. We demonstrate that these platforms can effectively treat two disease models [type I hereditary tyrosinemia (HT-I) and mucopolysaccharidosis type I (MPS-I)] in mice by HDR-based correction of the disease allele. These results will enable the engineering of single-vector AAVs that can achieve diverse therapeutic genome editing outcomes.<\/jats:p>","DOI":"10.1038\/s41467-021-26518-y","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T07:03:52Z","timestamp":1635750232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0961-7299","authenticated-orcid":false,"given":"Raed","family":"Ibraheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7409-8344","authenticated-orcid":false,"given":"Phillip W. L.","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Javeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s C.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk","family":"Namkung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eraj Shafiq","family":"Khokhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Mintzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Maitland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7754-8945","authenticated-orcid":false,"given":"Emmanouela","family":"Tsagkaraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7042-201X","authenticated-orcid":false,"given":"Scot A.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9079-2360","authenticated-orcid":false,"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athma A.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9797-8042","authenticated-orcid":false,"given":"Wen","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0097-9012","authenticated-orcid":false,"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0881-0310","authenticated-orcid":false,"given":"Erik J.","family":"Sontheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"26518_CR1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816\u2013821 (2012).","journal-title":"Science"},{"key":"26518_CR2","doi-asserted-by":"publisher","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","volume":"109","author":"G Gasiunas","year":"2012","unstructured":"Gasiunas, G., Barrangou, R., Horvath, P. & Siksnys, V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl Acad. Sci. USA 109, E2579\u2013E2586 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"26518_CR3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"26518_CR4","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823\u2013826 (2013).","journal-title":"Science"},{"key":"26518_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nbt.2501","volume":"31","author":"WY Hwang","year":"2013","unstructured":"Hwang, W. Y. et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 31, 227\u2013229 (2013).","journal-title":"Nat. Biotechnol."},{"key":"26518_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nbt.2507","volume":"31","author":"SW Cho","year":"2013","unstructured":"Cho, S. W., Kim, S., Kim, J. M. & Kim, J.-S. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 31, 230\u2013232 (2013).","journal-title":"Nat. Biotechnol."},{"key":"26518_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nbt.2508","volume":"31","author":"W Jiang","year":"2013","unstructured":"Jiang, W., Bikard, D., Cox, D., Zhang, F. & Marraffini, L. A. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31, 233\u2013239 (2013).","journal-title":"Nat. Biotechnol."},{"key":"26518_CR8","doi-asserted-by":"publisher","first-page":"e00471","DOI":"10.7554\/eLife.00471","volume":"2","author":"M Jinek","year":"2013","unstructured":"Jinek, M. et al. RNA-programmed genome editing in human cells. Elife 2, e00471 (2013).","journal-title":"Elife"},{"key":"26518_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","volume":"163","author":"B Zetsche","year":"2015","unstructured":"Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163, 759\u2013771 (2015).","journal-title":"Cell"},{"key":"26518_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41586-019-0908-x","volume":"566","author":"J-J Liu","year":"2019","unstructured":"Liu, J.-J. et al. CasX enzymes comprise a distinct family of RNA-guided genome editors. Nature 566, 218\u2013223 (2019).","journal-title":"Nature"},{"key":"26518_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1126\/science.abb1400","volume":"369","author":"P Pausch","year":"2020","unstructured":"Pausch, P. et al. CRISPR-Cas\u03a6 from huge phages is a hypercompact genome editor. Science 369, 333\u2013337 (2020).","journal-title":"Science"},{"key":"26518_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","volume":"578","author":"JA Doudna","year":"2020","unstructured":"Doudna, J. A. The promise and challenge of therapeutic genome editing. Nature 578, 229\u2013236 (2020).","journal-title":"Nature"},{"key":"26518_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824\u2013844 (2020).","journal-title":"Nat. Biotechnol."},{"key":"26518_CR14","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1128\/JB.01412-07","volume":"190","author":"H Deveau","year":"2008","unstructured":"Deveau, H. et al. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J. Bacteriol. 190, 1390\u20131400 (2008).","journal-title":"J. Bacteriol."},{"key":"26518_CR15","doi-asserted-by":"publisher","first-page":"9275","DOI":"10.1093\/nar\/gkr606","volume":"39","author":"R Sapranauskas","year":"2011","unstructured":"Sapranauskas, R. et al. The Streptococcus thermophilus CRISPR\/Cas system provides immunity in Escherichia coli. Nucleic Acids Res. 39, 9275\u20139282 (2011).","journal-title":"Nucleic Acids Res."},{"key":"26518_CR16","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41556-019-0425-z","volume":"21","author":"CD Yeh","year":"2019","unstructured":"Yeh, C. D., Richardson, C. D. & Corn, J. E. Advances in genome editing through control of DNA repair pathways. Nat. Cell Biol. 21, 1468\u20131478 (2019).","journal-title":"Nat. Cell Biol."},{"key":"26518_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees, H. A. & Liu, D. R. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 19, 770\u2013788 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"26518_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"26518_CR19","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nature09886","volume":"471","author":"E Deltcheva","year":"2011","unstructured":"Deltcheva, E. et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471, 602\u2013607 (2011).","journal-title":"Nature"},{"key":"26518_CR20","doi-asserted-by":"publisher","first-page":"15644","DOI":"10.1073\/pnas.1313587110","volume":"110","author":"Z Hou","year":"2013","unstructured":"Hou, Z. et al. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc. Natl Acad. Sci. USA 110, 15644\u201315649 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"26518_CR21","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nmeth.2681","volume":"10","author":"KM Esvelt","year":"2013","unstructured":"Esvelt, K. M. et al. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat. Methods 10, 1116\u20131121 (2013).","journal-title":"Nat. Methods"},{"key":"26518_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran, F. A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186\u2013191 (2015).","journal-title":"Nature"},{"key":"26518_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14500","volume":"8","author":"E Kim","year":"2017","unstructured":"Kim, E. et al. In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni. Nat. Commun. 8, 14500 (2017).","journal-title":"Nat. Commun."},{"key":"26518_CR24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.molcel.2018.12.003","volume":"73","author":"A Edraki","year":"2019","unstructured":"Edraki, A. et al. A compact, high-accuracy Cas9 with a dinucleotide PAM for in vivo genome editing. Mol. Cell 73, 714\u2013726.e4 (2019).","journal-title":"Mol. Cell"},{"key":"26518_CR25","doi-asserted-by":"publisher","first-page":"e3000686","DOI":"10.1371\/journal.pbio.3000686","volume":"18","author":"Z Hu","year":"2020","unstructured":"Hu, Z. et al. A compact Cas9 ortholog from Staphylococcus Auricularis (SauriCas9) expands the DNA targeting scope. PLoS Biol. 18, e3000686 (2020).","journal-title":"PLoS Biol."},{"key":"26518_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","volume":"181","author":"D Wang","year":"2020","unstructured":"Wang, D., Zhang, F. & Gao, G. CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors. Cell 181, 136\u2013150 (2020).","journal-title":"Cell"},{"key":"26518_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1515-0","volume":"19","author":"R Ibraheim","year":"2018","unstructured":"Ibraheim, R. et al. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo. Genome Biol. 19, 137 (2018).","journal-title":"Genome Biol."},{"key":"26518_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1101\/gr.255414.119","volume":"30","author":"D Agudelo","year":"2020","unstructured":"Agudelo, D. et al. Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9. Genome Res. 30, 107\u2013117 (2020).","journal-title":"Genome Res."},{"key":"26518_CR29","doi-asserted-by":"crossref","unstructured":"Wen, J. et al. Single AAV-mediated CRISPR\/Nme2Cas9 efficiently reduces mutant hTTR expression in a transgenic mouse model of transthyretin amyloidosis. Mol. Ther. 0 (2021).","DOI":"10.1016\/j.ymthe.2021.05.010"},{"key":"26518_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0817-8","volume":"16","author":"AE Friedland","year":"2015","unstructured":"Friedland, A. E. et al. Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications. Genome Biol. 16, 257 (2015).","journal-title":"Genome Biol."},{"key":"26518_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","volume":"25","author":"ML Maeder","year":"2019","unstructured":"Maeder, M. L. et al. Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. Nat. Med. 25, 229\u2013233 (2019).","journal-title":"Nat. Med."},{"key":"26518_CR32","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.4142\/jvs.2020.21.e26","volume":"21","author":"YJ Chang","year":"2020","unstructured":"Chang, Y. J. et al. In vivo multiplex gene targeting with Streptococcus pyogens and Campylobacter jejuni Cas9 for pancreatic cancer modeling in wild-type animal. J. Vet. Sci. 21, e26 (2020).","journal-title":"J. Vet. Sci."},{"key":"26518_CR33","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/mt.2016.8","volume":"24","author":"CM Lee","year":"2016","unstructured":"Lee, C. M., Cradick, T. J. & Bao, G. The Neisseria meningitidis CRISPR-Cas9 system enables specific genome editing in mammalian cells. Mol. Ther. 24, 645\u2013654 (2016).","journal-title":"Mol. Ther."},{"key":"26518_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1591-1","volume":"19","author":"N Amrani","year":"2018","unstructured":"Amrani, N. et al. NmeCas9 is an intrinsically high-fidelity genome-editing platform. Genome Biol. 19, 214 (2018).","journal-title":"Genome Biol."},{"key":"26518_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cels.2016.12.010","volume":"4","author":"N Bisaria","year":"2017","unstructured":"Bisaria, N., Jarmoskaite, I. & Herschlag, D. Lessons from enzyme kinetics reveal specificity principles for RNA-guided nucleases in RNA interference and CRISPR-based genome editing. Cell Syst. 4, 21\u201329 (2017).","journal-title":"Cell Syst."},{"key":"26518_CR36","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nbt.3404","volume":"33","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver, B. P. et al. Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat. Biotechnol. 33, 1293\u20131298 (2015).","journal-title":"Nat. Biotechnol."},{"key":"26518_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab148","author":"Z Hu","year":"2021","unstructured":"Hu, Z. et al. Discovery and engineering of small SlugCas9 with broad targeting range and high specificity and activity. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkab148 (2021).","journal-title":"Nucleic Acids Res."},{"key":"26518_CR38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41586-018-0686-x","volume":"563","author":"MW Shen","year":"2018","unstructured":"Shen, M. W. et al. Predictable and precise template-free CRISPR editing of pathogenic variants. Nature 563, 646\u2013651 (2018).","journal-title":"Nature"},{"key":"26518_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1076-8","volume":"568","author":"S Iyer","year":"2019","unstructured":"Iyer, S. et al. Precise therapeutic gene correction by a simple nuclease-induced double-stranded break. Nature 568, 561\u2013565 (2019).","journal-title":"Nature"},{"key":"26518_CR40","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nbt.3469","volume":"34","author":"Y Yang","year":"2016","unstructured":"Yang, Y. et al. A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice. Nat. Biotechnol. 34, 334\u2013338 (2016).","journal-title":"Nat. Biotechnol."},{"key":"26518_CR41","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.neuron.2017.10.004","volume":"96","author":"J Nishiyama","year":"2017","unstructured":"Nishiyama, J., Mikuni, T. & Yasuda, R. Virus-mediated genome editing via homology-directed repair in mitotic and postmitotic cells in mammalian brain. Neuron 96, 755\u2013768.e5 (2017).","journal-title":"Neuron"},{"key":"26518_CR42","doi-asserted-by":"publisher","first-page":"e128863","DOI":"10.1172\/jci.insight.128863","volume":"5","author":"A De Caneva","year":"2019","unstructured":"De Caneva, A. et al. Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases. JCI Insight 5, e128863 (2019).","journal-title":"JCI Insight"},{"key":"26518_CR43","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-018-0209-1","volume":"24","author":"L Villiger","year":"2018","unstructured":"Villiger, L. et al. Treatment of a metabolic liver disease by in vivo genome base editing in adult mice. Nat. Med. 24, 1519\u20131525 (2018).","journal-title":"Nat. Med."},{"key":"26518_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41421-019-0109-7","volume":"5","author":"J Winter","year":"2019","unstructured":"Winter, J. et al. Targeted exon skipping with AAV-mediated split adenine base editors. Cell Disco. 5, 41 (2019).","journal-title":"Cell Disco."},{"key":"26518_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","volume":"4","author":"JM Levy","year":"2020","unstructured":"Levy, J. M. et al. Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat. Biomed. Eng. 4, 97\u2013110 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"26518_CR46","doi-asserted-by":"publisher","first-page":"eaay9101","DOI":"10.1126\/scitranslmed.aay9101","volume":"12","author":"W-H Yeh","year":"2020","unstructured":"Yeh, W.-H. et al. In vivo base editing restores sensory transduction and transiently improves auditory function in a mouse model of recessive deafness. Sci. Transl. Med. 12, eaay9101 (2020).","journal-title":"Sci. Transl. Med."},{"key":"26518_CR47","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.ymthe.2020.01.005","volume":"28","author":"CKW Lim","year":"2020","unstructured":"Lim, C. K. W. et al. Treatment of a mouse model of ALS by in vivo base editing. Mol. Ther. 28, 1177\u20131189 (2020).","journal-title":"Mol. Ther."},{"key":"26518_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18715-y","volume":"11","author":"MT Nguyen Tran","year":"2020","unstructured":"Nguyen Tran, M. T. et al. Engineering domain-inlaid SaCas9 adenine base editors with reduced RNA off-targets and increased on-target DNA editing. Nat. Commun. 11, 4871 (2020).","journal-title":"Nat. Commun."},{"key":"26518_CR49","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/hum.2018.015","volume":"29","author":"C Hinderer","year":"2018","unstructured":"Hinderer, C. et al. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum. Gene Ther. 29, 285\u2013298 (2018).","journal-title":"Hum. Gene Ther."},{"key":"26518_CR50","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nbt.4182","volume":"36","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol. Nat. Biotechnol. 36, 717\u2013725 (2018).","journal-title":"Nat. Biotechnol."},{"key":"26518_CR51","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1089\/hum.2020.182","volume":"31","author":"JM Wilson","year":"2020","unstructured":"Wilson, J. M. & Flotte, T. R. Moving forward after two deaths in a gene therapy trial of myotubular myopathy. Hum. Gene Ther. 31, 695\u2013696 (2020).","journal-title":"Hum. Gene Ther."},{"key":"26518_CR52","doi-asserted-by":"publisher","first-page":"100764","DOI":"10.1016\/j.isci.2019.100764","volume":"23","author":"SA Krooss","year":"2020","unstructured":"Krooss, S. A. et al. Ex vivo\/in vivo gene editing in hepatocytes using \u2018all-in-one\u2019 CRISPR-adeno-associated virus vectors with a self-linearizing repair template. iScience 23, 100764 (2020).","journal-title":"iScience"},{"key":"26518_CR53","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1261\/rna.071704.119","volume":"25","author":"J Lee","year":"2019","unstructured":"Lee, J. et al. Tissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteins. RNA 25, 1421\u20131431 (2019).","journal-title":"RNA"},{"key":"26518_CR54","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-biochem-011420-111224","volume":"89","author":"AR Davidson","year":"2020","unstructured":"Davidson, A. R. et al. Anti-CRISPRs: protein inhibitors of CRISPR-Cas systems. Annu. Rev. Biochem. 89, 309\u2013332 (2020).","journal-title":"Annu. Rev. Biochem."},{"key":"26518_CR55","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41592-020-0771-6","volume":"17","author":"ND Marino","year":"2020","unstructured":"Marino, N. D., Pinilla-Redondo, R., Cs\u00f6rg\u0151, B. & Bondy-Denomy, J. Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies. Nat. Methods 17, 471\u2013479 (2020).","journal-title":"Nat. Methods"},{"key":"26518_CR56","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.molcel.2019.09.025","volume":"76","author":"W Sun","year":"2019","unstructured":"Sun, W. et al. Structures of Neisseria meningitidis Cas9 complexes in catalytically poised and anti-CRISPR-inhibited states. Mol. Cell 76, 938\u2013952.e5 (2019).","journal-title":"Mol. Cell"},{"key":"26518_CR57","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1101\/gr.231936.117","volume":"28","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. CRISPR RNAs trigger innate immune responses in human cells. Genome Res. 28, 367\u2013373 (2018).","journal-title":"Genome Res."},{"key":"26518_CR58","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nbt.3290","volume":"33","author":"A Hendel","year":"2015","unstructured":"Hendel, A. et al. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat. Biotechnol. 33, 985\u2013989 (2015).","journal-title":"Nat. Biotechnol."},{"key":"26518_CR59","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt, R. J. et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159, 440\u2013455 (2014).","journal-title":"Cell"},{"key":"26518_CR60","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1093\/nar\/gkv1542","volume":"44","author":"JM Geisinger","year":"2016","unstructured":"Geisinger, J. M., Turan, S., Hernandez, S., Spector, L. P. & Calos, M. P. In vivo blunt-end cloning through CRISPR\/Cas9-facilitated non-homologous end-joining. Nucleic Acids Res. 44, e76 (2016).","journal-title":"Nucleic Acids Res."},{"key":"26518_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07310-x","volume":"9","author":"MF Bolukbasi","year":"2018","unstructured":"Bolukbasi, M. F. et al. Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing. Nat. Commun. 9, 4856 (2018).","journal-title":"Nat. Commun."},{"key":"26518_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1518-x","volume":"19","author":"T Guo","year":"2018","unstructured":"Guo, T. et al. Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR\/Cas9-mediated genome editing. Genome Biol. 19, 170 (2018).","journal-title":"Genome Biol."},{"key":"26518_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4561-9","volume":"19","author":"G Giannoukos","year":"2018","unstructured":"Giannoukos, G. et al. UDiTaSTM, a genome editing detection method for indels and genome rearrangements. BMC Genomics 19, 212 (2018).","journal-title":"BMC Genomics"},{"key":"26518_CR64","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.ymthe.2017.03.028","volume":"25","author":"J Xie","year":"2017","unstructured":"Xie, J. et al. Short DNA hairpins compromise recombinant adeno-associated virus genome homogeneity. Mol. Ther. 25, 1363\u20131374 (2017).","journal-title":"Mol. Ther."},{"key":"26518_CR65","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.omtm.2018.02.002","volume":"9","author":"PWL Tai","year":"2018","unstructured":"Tai, P. W. L. et al. Adeno-associated virus genome population sequencing achieves full vector genome resolution and reveals human-vector chimeras. Mol. Ther. Methods Clin. Dev. 9, 130\u2013141 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"26518_CR66","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.omtm.2020.07.007","volume":"18","author":"NT Tran","year":"2020","unstructured":"Tran, N. T. et al. AAV-genome population sequencing of vectors packaging CRISPR components reveals design-influenced heterogeneity. Mol. Ther. Methods Clin. Dev. 18, 639\u2013651 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"26518_CR67","unstructured":"Gao, G. & Sena-Estevez, M. in Molecular Cloning: A Laboratory Manual Vol. 2 (eds Green, M. R. & Sambrook, J.) 1209\u20131313 (Cold Spring Harbor Laboratory Press, 2012)."},{"key":"26518_CR68","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1101\/gad.7.12a.2298","volume":"7","author":"M Grompe","year":"1993","unstructured":"Grompe, M. et al. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev. 7, 2298\u20132307 (1993).","journal-title":"Genes Dev."},{"key":"26518_CR69","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1073\/pnas.98.2.641","volume":"98","author":"JL Aponte","year":"2001","unstructured":"Aponte, J. L. et al. Point mutations in the murine fumarylacetoacetate hydrolase gene: animal models for the human genetic disorder hereditary tyrosinemia type 1. Proc. Natl Acad. Sci. USA 98, 641\u2013645 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"26518_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12642","volume":"7","author":"FP Pankowicz","year":"2016","unstructured":"Pankowicz, F. P. et al. Reprogramming metabolic pathways in vivo with CRISPR\/Cas9 genome editing to treat hereditary tyrosinaemia. Nat. Commun. 7, 12642 (2016).","journal-title":"Nat. Commun."},{"key":"26518_CR71","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","volume":"25","author":"CE Nelson","year":"2019","unstructured":"Nelson, C. E. et al. Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nat. Med. 25, 427\u2013432 (2019).","journal-title":"Nat. Med."},{"key":"26518_CR72","doi-asserted-by":"publisher","first-page":"e0229276","DOI":"10.1371\/journal.pone.0229276","volume":"15","author":"TN Nguyen","year":"2020","unstructured":"Nguyen, T. N., Nguyen, H. Q. & Le, D.-H. Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses. PLoS ONE 15, e0229276 (2020).","journal-title":"PLoS ONE"},{"key":"26518_CR73","doi-asserted-by":"publisher","first-page":"e108424","DOI":"10.1371\/journal.pone.0108424","volume":"9","author":"LJ Zhu","year":"2014","unstructured":"Zhu, L. J., Holmes, B. R., Aronin, N. & Brodsky, M. H. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems. PLoS ONE 9, e108424 (2014).","journal-title":"PLoS ONE"},{"key":"26518_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04625-5","volume":"7","author":"T Ohmori","year":"2017","unstructured":"Ohmori, T. et al. CRISPR\/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice. Sci. Rep. 7, 4159 (2017).","journal-title":"Sci. Rep."},{"key":"26518_CR75","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.omtm.2019.12.004","volume":"17","author":"DY Richards","year":"2020","unstructured":"Richards, D. Y. et al. AAV-mediated CRISPR\/Cas9 gene editing in murine phenylketonuria. Mol. Ther. Methods Clin. Dev. 17, 234\u2013245 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"26518_CR76","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.omtn.2018.12.008","volume":"14","author":"J Gao","year":"2018","unstructured":"Gao, J. et al. Viral vector-based delivery of CRISPR\/Cas9 and donor DNA for homology-directed repair in an in vitro model for canine Hemophilia B. Mol. Ther. Nucleic Acids 14, 364\u2013376 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"26518_CR77","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","volume":"1","author":"K Lee","year":"2017","unstructured":"Lee, K. et al. Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair. Nat. Biomed. Eng. 1, 889\u2013901 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"26518_CR78","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s41563-019-0385-5","volume":"18","author":"R Shahbazi","year":"2019","unstructured":"Shahbazi, R. et al. Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations. Nat. Mater. 18, 1124\u20131132 (2019).","journal-title":"Nat. Mater."},{"key":"26518_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1164-8","volume":"18","author":"J-P Zhang","year":"2017","unstructured":"Zhang, J.-P. et al. Efficient precise knockin with a double cut HDR donor after CRISPR\/Cas9-mediated double-stranded DNA cleavage. Genome Biol. 18, 35 (2017).","journal-title":"Genome Biol."},{"key":"26518_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15334","volume":"8","author":"G Petris","year":"2017","unstructured":"Petris, G. et al. Hit and go CAS9 delivered through a lentiviral based self-limiting circuit. Nat. Commun. 8, 15334 (2017).","journal-title":"Nat. Commun."},{"key":"26518_CR81","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1016\/j.celrep.2017.08.075","volume":"20","author":"N Merienne","year":"2017","unstructured":"Merienne, N. et al. The self-inactivating KamiCas9 system for the editing of CNS disease genes. Cell Rep. 20, 2980\u20132991 (2017).","journal-title":"Cell Rep."},{"key":"26518_CR82","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.omtm.2018.11.009","volume":"12","author":"A Li","year":"2019","unstructured":"Li, A. et al. A self-deleting AAV-CRISPR system for in vivo genome editing. Mol. Ther. Methods Clin. Dev. 12, 111\u2013122 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"26518_CR83","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ymthe.2016.12.006","volume":"25","author":"G-X Ruan","year":"2017","unstructured":"Ruan, G.-X. et al. CRISPR\/Cas9-mediated genome editing as a therapeutic approach for leber congenital amaurosis 10. Mol. Ther. 25, 331\u2013341 (2017).","journal-title":"Mol. Ther."},{"key":"26518_CR84","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1089\/hum.2019.021","volume":"30","author":"F Li","year":"2019","unstructured":"Li, F. et al. Utility of self-destructing CRISPR\/Cas constructs for targeted gene editing in the retina. Hum. Gene Ther. 30, 1349\u20131360 (2019).","journal-title":"Hum. Gene Ther."},{"key":"26518_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-4-11","volume":"4","author":"KC Murphy","year":"2003","unstructured":"Murphy, K. C. & Campellone, K. G. Lambda red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli. BMC Mol. Biol. 4, 11 (2003).","journal-title":"BMC Mol. Biol."},{"key":"26518_CR86","first-page":"e02321","volume":"9","author":"J Lee","year":"2018","unstructured":"Lee, J. et al. Potent Cas9 inhibition in bacterial and human cells by AcrIIC4 and AcrIIC5 anti-CRISPR proteins. MBio 9, e02321\u201318 (2018).","journal-title":"MBio"},{"key":"26518_CR87","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.1648","volume":"8","author":"MT Certo","year":"2011","unstructured":"Certo, M. T. et al. Tracking genome engineering outcome at individual DNA breakpoints. Nat. Methods 8, 671\u2013676 (2011).","journal-title":"Nat. Methods"},{"key":"26518_CR88","doi-asserted-by":"publisher","unstructured":"Iyer, S. et al. Efficient homology-directed repair with circular ssDNA donors. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/864199 (2019).","DOI":"10.1101\/864199"},{"key":"26518_CR89","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nbt.2884","volume":"32","author":"H Yin","year":"2014","unstructured":"Yin, H. et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 32, 551\u2013553 (2014).","journal-title":"Nat. Biotechnol."},{"key":"26518_CR90","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nature20565","volume":"540","author":"K Suzuki","year":"2016","unstructured":"Suzuki, K. et al. In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration. Nature 540, 144\u2013149 (2016).","journal-title":"Nature"},{"key":"26518_CR91","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0925-4439(98)00046-5","volume":"1407","author":"S Bunge","year":"1998","unstructured":"Bunge, S. et al. Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies. Biochim. Biophys. Acta 1407, 249\u2013256 (1998).","journal-title":"Biochim. Biophys. Acta"},{"key":"26518_CR92","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ymgme.2013.05.016","volume":"109","author":"E Oussoren","year":"2013","unstructured":"Oussoren, E. et al. Residual \u03b1-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients. Mol. Genet. Metab. 109, 377\u2013381 (2013).","journal-title":"Mol. Genet. Metab."},{"key":"26518_CR93","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ymgme.2009.08.002","volume":"99","author":"D Wang","year":"2010","unstructured":"Wang, D. et al. Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation. Mol. Genet. Metab. 99, 62\u201371 (2010).","journal-title":"Mol. Genet. Metab."},{"key":"26518_CR94","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.omtm.2019.04.003","volume":"13","author":"DJ Palmer","year":"2019","unstructured":"Palmer, D. J., Turner, D. L. & Ng, P. Production of CRISPR\/Cas9-mediated self-cleaving helper-dependent adenoviruses. Mol. Ther. Methods Clin. Dev. 13, 432\u2013439 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"26518_CR95","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.omtm.2021.02.005","volume":"20","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. In vivo PCSK9 gene editing using an all-in-one self-cleavage AAV-CRISPR system. Mol. Ther. Methods Clin. Dev. 20, 652\u2013659 (2021).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"26518_CR96","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.ymthe.2020.10.006","volume":"29","author":"KJ Tatiossian","year":"2021","unstructured":"Tatiossian, K. J. et al. Rational selection of CRISPR-Cas9 guide RNAs for homology-directed genome editing. Mol. Ther. 29, 1057\u20131069 (2021).","journal-title":"Mol. Ther."},{"key":"26518_CR97","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2020.042","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Induced liver regeneration enhances CRISPR\/Cas9-mediated gene repair in tyrosinemia type 1. Hum. Gene Ther. https:\/\/doi.org\/10.1089\/hum.2020.042 (2020).","journal-title":"Hum. Gene Ther."},{"key":"26518_CR98","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10\u201312 (2011).","journal-title":"EMBnet. J."},{"key":"26518_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12449-2","volume":"10","author":"KS Hanlon","year":"2019","unstructured":"Hanlon, K. S. et al. High levels of AAV vector integration into CRISPR-induced DNA breaks. Nat. Commun. 10, 4439 (2019).","journal-title":"Nat. Commun."},{"key":"26518_CR100","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at arXiv [q-bio.GN] (2013)."},{"key":"26518_CR101","first-page":"Unit 19.10.1","volume":"Chapter 19","author":"D Blankenberg","year":"2010","unstructured":"Blankenberg, D. et al. Galaxy: a web-based genome analysis tool for experimentalists. Curr. Protoc. Mol. Biol. Chapter 19, Unit 19.10.1\u201321 (2010).","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"26518_CR102","doi-asserted-by":"crossref","unstructured":"de Koning, W. et al. NanoGalaxy: nanopore long-read sequencing data analysis in Galaxy. Gigascience 9, giaa105 (2020).","DOI":"10.1093\/gigascience\/giaa105"},{"key":"26518_CR103","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1101\/gr.4086505","volume":"15","author":"B Giardine","year":"2005","unstructured":"Giardine, B. et al. Galaxy: a platform for interactive large-scale genome analysis. Genome Res. 15, 1451\u20131455 (2005).","journal-title":"Genome Res."},{"key":"26518_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-8-r86","volume":"11","author":"J Goecks","year":"2010","unstructured":"Goecks, J., Nekrutenko, A. & Taylor, J., Galaxy Team. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol. 11, R86 (2010).","journal-title":"Genome Biol."},{"key":"26518_CR105","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"26518_CR106","doi-asserted-by":"publisher","first-page":"11.12.1","DOI":"10.1002\/0471250953.bi1112s47","volume":"47","author":"AR Quinlan","year":"2014","unstructured":"Quinlan, A. R. BEDTools: the Swiss-Army Tool for genome feature analysis. Curr. Protoc. Bioinforma. 47, 11.12.1\u201334 (2014).","journal-title":"Curr. Protoc. Bioinforma."},{"key":"26518_CR107","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"26518_CR108","doi-asserted-by":"publisher","first-page":"W537","DOI":"10.1093\/nar\/gky379","volume":"46","author":"E Afgan","year":"2018","unstructured":"Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 46, W537\u2013W544 (2018).","journal-title":"Nucleic Acids Res."},{"key":"26518_CR109","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/bioinformatics\/btq461","volume":"26","author":"RC Edgar","year":"2010","unstructured":"Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460\u20132461 (2010).","journal-title":"Bioinformatics"},{"key":"26518_CR110","doi-asserted-by":"publisher","unstructured":"Edwards, J. A. & Edwards, R. A. Fastq-pair: efficient synchronization of paired-end fastq files. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/552885 (2019).","DOI":"10.1101\/552885"},{"key":"26518_CR111","doi-asserted-by":"publisher","first-page":"D493","DOI":"10.1093\/nar\/gkh103","volume":"32","author":"D Karolchik","year":"2004","unstructured":"Karolchik, D. et al. The UCSC Table Browser data retrieval tool. Nucleic Acids Res. 32, D493\u2013D496 (2004).","journal-title":"Nucleic Acids Res."},{"key":"26518_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-020-6714-x","volume":"21","author":"O Yukselen","year":"2020","unstructured":"Yukselen, O., Turkyilmaz, O., Ozturk, A. R., Garber, M. & Kucukural, A. DolphinNext: a distributed data processing platform for high throughput genomics. BMC Genomics 21, 310 (2020).","journal-title":"BMC Genomics"},{"key":"26518_CR113","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ymgme.2011.10.005","volume":"105","author":"D Wang","year":"2012","unstructured":"Wang, D. et al. The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse. Mol. Genet. Metab. 105, 116\u2013125 (2012).","journal-title":"Mol. Genet. Metab."},{"key":"26518_CR114","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nbt.4219","volume":"36","author":"D Wang","year":"2018","unstructured":"Wang, D. et al. Cas9-mediated allelic exchange repairs compound heterozygous recessive mutations in mice. Nat. Biotechnol. 36, 839\u2013842 (2018).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26518-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26518-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26518-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T11:47:18Z","timestamp":1669981638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26518-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["26518"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-26518-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.09.333997","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"assertion":[{"value":"3 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: A patent application has been filed on technologies related to this work by the University of Massachusetts Medical School [Names of inventors: Erik J. Sontheimer, Raed Ibraheim, Wen Xue, Aamir Mir, Alireza Edraki, Ildar Gainetdinov. Application number: 16\/186,352. Status of application: Pending.] The following aspects of the manuscript are covered in the patent application: (1) Truncating of sgRNA sequence to create 121-nt sgRNA versions (Nme.sgRNA-121). (2) Truncating of sgRNA sequence to create 100-nt sgRNA versions (Nme.sgRNA-100). (3) Minimized all-in-one AAV.Nme2Cas9.sgRNA vector backbone to a packaging size of 4.4\u2009Kb including its promoters and regulatory signals. (4) Dual-sgRNA AAV.NmeCas9 vector backbones. G.G. is a scientific co-founder of Voyager Therapeutics, Adrenas Therapeutics, and Aspa Therapeutics and holds equity in these companies. G.G. is an inventor on patents with potential royalties licensed to Voyager Therapeutics, Aspa Therapeutics, and other biopharmaceutical companies. E.J.S. is a co-founder and scientific advisor of Intellia Therapeutics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6267"}}